Beneficient filings document the regulatory record for a Nevada financial services company that provides alternative-asset exit opportunities, primary capital solutions, and related trust and custody services. Its disclosures cover Class A common stock, warrants, convertible preferred stock, customized trust vehicles, limited partner interests, and securities issued in primary capital transactions.
The company’s SEC filings include 8-K reports on operating results, unregistered equity issuances, debt agreements and repayments, litigation settlement matters, and other material events. Proxy materials document annual meeting proposals, shareholder voting results, incentive-plan amendments, board and governance matters, while periodic and exhibit disclosures provide additional information on financial condition, risk factors, and capital structure.
Beneficient reported that Nasdaq notified the company it is not meeting the minimum stockholders’ equity requirement because its Form 10-K for the year ended March 31, 2025 showed stockholders’ equity of ($34,925,000). This new deficiency under Nasdaq Listing Rule 5550(b)(1) will be considered by the Nasdaq Hearing Panel alongside existing issues.
The company already faced outstanding notices for failing to meet the periodic filing requirement under Rule 5250(c)(1) and the minimum bid price requirement under Rule 5550(a)(2). A hearing was held on August 26, 2025, and Beneficient filed its annual report within the Panel’s extension period. It is working with its auditor to complete and file the Form 10-Q for the quarter ended June 30, 2025, and may seek stockholder approval for a reverse stock split of its Class A and Class B common stock to help satisfy the bid price rule. The company cautions there is no assurance it will regain compliance with Nasdaq’s listing standards.
Beneficient (BENF) describes a technology-enabled fiduciary business built around its AltAccess platform to provide liquidity and primary capital for alternative assets. The company reports historical transaction activity of approximately $1.2 billion and states that Ben Liquidity's loan portfolio had a carrying value of $244.0 million with ExAlt Loan Collateral valued at $291.4 million (NAV $259.1 million) as of March 31, 2025. ExAlt Loans have earned stated interest of about $427.7 million through that date.
The filing discloses material operational and financial risks: a net loss of $0.8 million for fiscal 2025 and an accumulated deficit of $2.0 billion; approximately $117.9 million of debt outstanding as of March 31, 2025; identified material weakness in internal control over financial reporting; notice of Nasdaq noncompliance; HCLP has alleged events of default and sought collateral; and ongoing litigation involving the founder and related parties. The company also outlines growth initiatives including an ExchangeTrust Product Plan targeting up to $5 billion of fiduciary financings and automation of ~77% of transaction steps via AltAccess.
Beneficient filed a current report to note that it has released its financial results for the fourth quarter and year ended March 31, 2025. On September 29, 2025, the company issued a press release detailing these results, which is furnished as Exhibit 99.1.
The filing emphasizes that the press release is being furnished rather than filed, meaning it is not automatically subject to certain liability provisions of the Exchange Act and is not incorporated into other securities filings unless specifically referenced.
Beneficient received a determination from a Nasdaq Hearings Panel on September 9, 2025 granting the company more time to regain compliance with key Nasdaq listing rules. The extension covers the requirements to be current in SEC filings, maintain a minimum $1.00 bid price for its Class A common stock, and satisfy listing standards for its warrants.
The company is working with its auditor to complete and file its Annual Report on Form 10-K for the year ended March 31, 2025 and its Quarterly Report on Form 10-Q for the quarter ended June 30, 2025 within the extension period. If its share price does not recover enough to meet Nasdaq’s bid price rule, Beneficient expects to seek stockholder approval for a reverse stock split of both its Class A and Class B common stock. The company notes there is no assurance it will regain compliance within the granted extension, and its shares remain at risk of delisting if it cannot meet Nasdaq requirements.
Beneficient disclosed that Nasdaq has issued an additional notice on August 18, 2025 stating the company is not in compliance with Nasdaq Listing Rule 5250(c)(1) because it has not yet filed its Form 10-Q for the quarter ended June 30, 2025. This reporting deficiency may serve as a separate basis for delisting.
The company already faces potential delisting for failing to meet the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) and for not filing its Form 10-K for the year ended March 31, 2025. Beneficient has requested a hearing before a Nasdaq Hearings Panel, which will consider all outstanding notices. The company cautions there is no assurance it will satisfy the Panel’s conditions to remain listed.
Beneficient filed a Form 12b-25 to notify that its Quarterly Report on Form 10-Q for the quarter ended June 30, 2025 will be filed late. The company says it cannot meet the original deadline without unreasonable effort or expense because it is still completing work needed to finish its overdue Annual Report on Form 10-K for the year ended March 31, 2025 and the related audit procedures.
The filing reiterates that former CEO Brad Heppner resigned on June 19, 2025 after he refused a requested formal interview about certain documents and information provided to the company’s auditors in 2019. The board appointed James G. Silk as interim CEO on July 20, 2025. Beneficient states it intends to file the 10-Q promptly after the 10-K is completed and filed but has not yet finished compiling and analyzing supporting documentation or accounting for the June 30, 2025 quarter, and therefore cannot reasonably estimate changes in results versus the prior-year period.
Hatteras Investment Partners, LP reports beneficial ownership of 562,749 shares of Beneficient Class A common stock, representing approximately 6.7% of the class. The filing states Hatteras is a Delaware limited partnership acting as an investment adviser with sole voting and dispositive power over these shares, which are held for one or more advisory clients. The filing notes that Hatteras Master Fund, LP has an interest equal to 5.6% of the class. Hatteras disclaims direct beneficial ownership except to the extent of any pecuniary interest and confirms the securities are held in the ordinary course of business and not to influence control of the issuer.
Form 3 Highlights
Interim CEO James G. Silk filed his initial statement of beneficial ownership for Beneficient (BENF) as of 20 Jul 2025.
- Direct ownership: 2,397 Class A shares. This total includes 282 shares issuable from 225 REUs (2018 plan) and 1,204 shares from 1,204 RSUs (2023 plan). Remaining tranches vest through 1 Apr 2026 and 1 Sep 2027.
- Derivative interests: 1,362 BCH Class S units linked to Preferred A-0 accounts and 5,449 Class S units linked to Preferred A-1 accounts. Both series are convertible 1-for-1 into BENF Class A shares; conversions are subject to price floors of at least $840 and, for A-1 units, a 20% annual cap until 2029 unless price triggers lift the limit.
- All derivative units are currently convertible and have no stated expiration. Exchange requires 61-day notice and trading-window compliance.
No purchases or sales were reported; the filing solely discloses existing holdings. Operational, financial and capital structure impacts are immaterial in the near term, but the disclosure underscores incentive alignment between management and shareholders.
Beneficient (BENF) Form 4 shows Global Head of Organizations & Distribution Jeff Welday acquired 30,687 Class A shares on 21 Jul 2025 through an immediately-vesting restricted stock unit (RSU) grant made under the 2023 Equity Incentive Plan. The shares were issued at $0 cost and coded “A” (acquisition), indicating they were awarded, not purchased on the open market.
Following the settlement, Welday’s direct beneficial ownership rises to 172,394 shares. This total includes prior equity awards: 61,592 RSUs granted 14 Jan 2025, 28,320 RSUs granted 15 Jul 2023, multiple REU awards from 2018-2022, and a 1,670-share RSU grant dated 16 Jan 2025. No derivative securities or sales were reported.
The filing reflects routine executive compensation and signals increased insider alignment but only modest dilution to existing shareholders. Because no open-market buying or selling occurred, immediate trading impact is expected to be minimal.